Nanocarrier SIroliMus-coated balloon-based percutaneous coronary intervention (PCI) versus drug-eluting stent (DES)-onLy PCI in patients with diabetes mellitus
In diabetic patients undergoing PCI for de novo CAD, an SCB-based strategy was associated with comparable 2-year outcomes to DES-only PCI, with signals of potential benefit in the highest clinical and anatomical risk subsets.
Authors
- Marco Frazzetto (ORCID: https://orcid.org/0000-0002-6543-7567)
- Giuseppe Calamita (ORCID: https://orcid.org/0000-0003-4666-9546)
- Gabriele Luigi Gasparini
- Cosmo Godino
- Damiano null Regazzoli
- Filippo Luca Gurgoglione
- Marco Luciano Rossi
- Gaia Filiberti
- Azeem Latib
- Bernhard Reimers
- Antonio Mangieri
- Pier Pasquale Leone
- Gennaro Sardella
- Giulio G. Stefanini
- Bernardo Cortese
- Antonio Colombo
- Mauro Chiarito
- Mauro Gitto
- Francesco Tartaglia
- Carlo Briguori
- Valentina Bernardini
Institutions
- University of Parma (IT)
- Albert Einstein College of Medicine (US)
- Valve (United States) (US)
- Montefiore Medical Center (US)
- Humanitas University (IT)
- Vita-Salute San Raffaele University (IT)
- University Hospitals of Cleveland (US)
- Policlinico Umberto I (IT)
- EMO GVM Centro Cuore Columbus (IT)
- Clinica Mediterranea (IT)
- Istituti di Ricovero e Cura a Carattere Scientifico (IT)
- IRCCS Humanitas Research Hospital (IT)
- Innova (Italy) (IT)
Publication Details
- Journal
- Cardiovascular Diabetology
- Published
- 2026-03-04
- DOI
- https://doi.org/10.1186/s12933-026-03110-6
- Primary Topic
- Coronary Interventions and Diagnostics
- Type
- article
- Field-Weighted Citation Impact
- 0.00